AAV Production
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring adeno-associated virus (AAV) production services from a qualified contract manufacturer to support in-house research activities, with a solicitation release estimated for May 1, 2027, and award targeted for September 1, 2027. The requirement stems from the absence of specialized equipment, technical expertise, and personnel capacity for AAV manufacturing at the scale needed; the contract manufacturer will deliver consistent, high-titer, research-grade AAV preparations meeting regulatory science quality standards.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Biologics Evaluation and Research Acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
We request funding for a contract AAV production service, as in-house production requires specialized equipment, technical expertise, and personnel time not currently available at the scale needed to support ongoing research activities. Outsourcing to a qualified contract manufacturer will ensure consistent, high-titer, research-grade AAV preparations that meet the quality standards required for regulatory science applications.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast